As with other prescription drugs, the Scripta app also navigates members to more affordable GLP-1 proven alternatives based on their plan design and formulary
The differences are significant, and misunderstanding them can cost you potency, money, or both
Immunohistochemical detection of alpha and beta cells was performed using rabbit anti-insulin (3014, 1:800, Cell Signaling Technology) and mouse anti glucagon (G2654, 1:1,000, Merck) as primary antibodies and goat anti-rabbit AF750 (A21039, 1:100, Invitrogen) and donkey anti-mouse AF555 (A32773, 1:200, Invitrogen) as secondary antibodies
Contact Purlife Medical today for personalized advice and guidance
The Market Opportunity: Numbers Tell the Story for GLP-1 Market research indicates that over 5 million Americans now take GLP-1 medications, with projections suggesting this number could grow to 20 million within three years